The medical benefits of mesenchymal stem cells (MSCs), the same type of cells used by Celltex in our proprietary isolation and banking technology, are far-reaching. Researchers in Vadodara, India have conducted a study using MSCs that may be helpful for those using insulin to treat diabetes. Dr. Rajini Vyas and her team began the study in 2006 and focused on MSCs. Through the process of differentiation, Islet-like Cell Aggregates (ICA), which are clusters of cells that produce hormones, are created … read more
Houston-based biotechnology company Celltex Therapeutics Corporation is proud to announce a partnership with the Arthritis Foundation South Central Region. The coming together of these organizations marks a milestone for the future of regenerative medicine for people who are living with arthritis. Founded in 2011 by David Eller and internationally-known spine surgeon, Dr. Stanley Jones, Celltex has been generating breakthroughs in the autologous (ones own) stem cell field to improve the quality of life for those suffering from injuries or vascular, … read more
MMQB.com released an intensive look into the number of professional athletes who are turning to adult mesenchymal stem cells (the kind that we all have in our own body and the same kind used by Celltex) to help them recover from sports-related injuries. According to the article published in late July, stem cell therapy is the next big breakthrough in sports medicine. Still, restrictions for use in the U.S. make stem cells an important and debated topic in regenerative medicine … read more
Celltex Therapeutics Corporation (Celltex) helped sponsor the Ninth Annual Joints in Action Golf Tournament, which invites golf enthusiasts to play a round for a good cause. The Tournament, founded by Dr. Bill Bryan and co-chaired by James Dumler and Lee Hollmann, took place on Thursday, August 28th at the Kingwood Country Club in Kingwood, TX, and honored Dr. Stanley Jones, chief medical officer at Celltex, as this year’s medical honoree. The annual charity event, which raises more than $200,000 every … read more
Houston-based biotechnology company Celltex Therapeutics Corporation took part in the National Basketball Retired Players Association (NBRPA) 2014 Legends World Sports Conference in Cancun, Mexico on August 22-24, 2014 sharing the potential of stem cell use in regenerative therapy for athletes. The annual conference attracted nearly 100 retired players from the NBA, ABA, WNBA and Harlem Globetrotters to network, participate in various workshops and unite in community service. Celltex, formed in 2011 by David G. Eller and internationally knows surgeon Dr. … read more
Researchers in Sydney, Australia have seen promising results in a study using Mesenchymal Stem Cells to treat neuropathic pain in female patients. Mesenchymal Stem Cells are the same type of cells used by Celltex in our exclusive technology. Click here to read more about the Australian trial results.
Veterinary surgeons at the University of Georgia have successfully used autologous mesenchymal stem cells to optimize a kidney transplant in a cat. Click here to read more.
Korean neuroscientists have found that when mesenchymal stem cells (MSCs) are transplanted into the brains of mice with Alzheimer’s disease, the cells stimulate neural growth and repair in the hippocampus, a key area in the brain damaged by Alzheimer’s. Click here to read more.
Researchers at Johns Hopkins University claim they have successfully used stem cells derived from body fat to deliver biological treatments directly to the brains of mice with the most common and aggressive form of brain tumor, significantly extending their lives. Click here to read more.
We are excited to announce that we will be sponsoring the 2014 Walk to Cure Arthritis to be held on May 3, 2014. For more information, please click here.